Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus
Aim. To investigate the association of variation in lipid-lowering response and endothelial function (EF) parameters after atorvastatin therapy in patients with type 2 diabetes mellitus (T2DM) with genetic markers of atherosclerosis.Methods. We included 97 patients with T2DM who were prescribed ator...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/036503a760eb48cb90d3b24cb9ff6ded |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:036503a760eb48cb90d3b24cb9ff6ded |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:036503a760eb48cb90d3b24cb9ff6ded2021-11-14T09:00:20ZPharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus2072-03512072-037810.14341/DM200342-7https://doaj.org/article/036503a760eb48cb90d3b24cb9ff6ded2016-07-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7851https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To investigate the association of variation in lipid-lowering response and endothelial function (EF) parameters after atorvastatin therapy in patients with type 2 diabetes mellitus (T2DM) with genetic markers of atherosclerosis.Methods. We included 97 patients with T2DM who were prescribed atorvastatin. Fasting lipid profiles and EF parameters were assessed before and after 12 months of statin therapy. For EF evaluation, we performed pulse-wave analysis during reactive hyperaemia. The genotypes for polymorphic markers were identified by real-time polymerase chain reaction with TaqMan probes. The statistical analysis included Wilcoxon, Mann–Whitney and Kruskal–Wallis tests. P-values <0.05 were considered statistically significant.Results. With statin therapy, PPARG2Pro/Pro patients had significantly lower TC and LDL-C levels than PPARG2 Pro/Ala and PPARG2 Ala/Ala patients (TC: 20.74% vs. 4.6% and 5.61%; p = 0.04 and LDL-C: 26.00% vs. 6.11% and 7.32%; p = 0.029). Patients with АРОЕЕ4/Е4 had significantly lower TC and TG levels than other АРОЕ patients (TC: -46.25% for Е4/Е4 vs. +33.33% for Е4/Е2, +5.73% for Е3/Е2, +11.80% for Е3/Е4, -10.92% for Е3/Е3, р = 0,01; TG: -56.52% for Е4/Е4 vs. +24.43% for Е4/Е2, +19.63% for Е3/Е2, +8.05% for Е3/Е4, -20.00% for Е3/Е3, р = 0.04). The patients with GG for TNFα G(238)A and GA for TNFα G(308)A had significantly greater amplitude of post-occlusive wave increase (Apw) than patients with GA for TNFα G(238)A and GG for TNFα G(308)A (+8.16 % vs. -0.93%, р = 0,04; +44% vs. -4.4%, p = 0.004, respectively).Conclusion. PPARG2Pro12Ala and АРОЕE2/Е3/Е4 polymorphism contributed to the between-patient variability in the response to statin therapy in patients with T2DM. Significant associations of the TNFαgene polymorphism with EF in patients with T2DM suggest an important role of inflammation in the pathogenesis of MVD.Nadezhda O. LebedevaOlga K. VikulovaAlexei G. NikitinMinara Sh. ShamkhalovaMarina V. ShestakovaIvan I. DedovEndocrinology Research Centrearticlestatinsendothelial functiont2dpolymorphic markersgenes pparg2apoetnf-αNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 3, Pp 204-211 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
statins endothelial function t2d polymorphic markers genes pparg2 apoe tnf-α Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
statins endothelial function t2d polymorphic markers genes pparg2 apoe tnf-α Nutritional diseases. Deficiency diseases RC620-627 Nadezhda O. Lebedeva Olga K. Vikulova Alexei G. Nikitin Minara Sh. Shamkhalova Marina V. Shestakova Ivan I. Dedov Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus |
| description |
Aim. To investigate the association of variation in lipid-lowering response and endothelial function (EF) parameters after atorvastatin therapy in patients with type 2 diabetes mellitus (T2DM) with genetic markers of atherosclerosis.Methods. We included 97 patients with T2DM who were prescribed atorvastatin. Fasting lipid profiles and EF parameters were assessed before and after 12 months of statin therapy. For EF evaluation, we performed pulse-wave analysis during reactive hyperaemia. The genotypes for polymorphic markers were identified by real-time polymerase chain reaction with TaqMan probes. The statistical analysis included Wilcoxon, Mann–Whitney and Kruskal–Wallis tests. P-values <0.05 were considered statistically significant.Results. With statin therapy, PPARG2Pro/Pro patients had significantly lower TC and LDL-C levels than PPARG2 Pro/Ala and PPARG2 Ala/Ala patients (TC: 20.74% vs. 4.6% and 5.61%; p = 0.04 and LDL-C: 26.00% vs. 6.11% and 7.32%; p = 0.029). Patients with АРОЕЕ4/Е4 had significantly lower TC and TG levels than other АРОЕ patients (TC: -46.25% for Е4/Е4 vs. +33.33% for Е4/Е2, +5.73% for Е3/Е2, +11.80% for Е3/Е4, -10.92% for Е3/Е3, р = 0,01; TG: -56.52% for Е4/Е4 vs. +24.43% for Е4/Е2, +19.63% for Е3/Е2, +8.05% for Е3/Е4, -20.00% for Е3/Е3, р = 0.04). The patients with GG for TNFα G(238)A and GA for TNFα G(308)A had significantly greater amplitude of post-occlusive wave increase (Apw) than patients with GA for TNFα G(238)A and GG for TNFα G(308)A (+8.16 % vs. -0.93%, р = 0,04; +44% vs. -4.4%, p = 0.004, respectively).Conclusion. PPARG2Pro12Ala and АРОЕE2/Е3/Е4 polymorphism contributed to the between-patient variability in the response to statin therapy in patients with T2DM. Significant associations of the TNFαgene polymorphism with EF in patients with T2DM suggest an important role of inflammation in the pathogenesis of MVD. |
| format |
article |
| author |
Nadezhda O. Lebedeva Olga K. Vikulova Alexei G. Nikitin Minara Sh. Shamkhalova Marina V. Shestakova Ivan I. Dedov |
| author_facet |
Nadezhda O. Lebedeva Olga K. Vikulova Alexei G. Nikitin Minara Sh. Shamkhalova Marina V. Shestakova Ivan I. Dedov |
| author_sort |
Nadezhda O. Lebedeva |
| title |
Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus |
| title_short |
Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus |
| title_full |
Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus |
| title_fullStr |
Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus |
| title_full_unstemmed |
Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus |
| title_sort |
pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus |
| publisher |
Endocrinology Research Centre |
| publishDate |
2016 |
| url |
https://doaj.org/article/036503a760eb48cb90d3b24cb9ff6ded |
| work_keys_str_mv |
AT nadezhdaolebedeva pharmacogeneticsofstatintherapyandtheendothelialfunctionparametersinpatientswithtype2diabetesmellitus AT olgakvikulova pharmacogeneticsofstatintherapyandtheendothelialfunctionparametersinpatientswithtype2diabetesmellitus AT alexeignikitin pharmacogeneticsofstatintherapyandtheendothelialfunctionparametersinpatientswithtype2diabetesmellitus AT minarashshamkhalova pharmacogeneticsofstatintherapyandtheendothelialfunctionparametersinpatientswithtype2diabetesmellitus AT marinavshestakova pharmacogeneticsofstatintherapyandtheendothelialfunctionparametersinpatientswithtype2diabetesmellitus AT ivanidedov pharmacogeneticsofstatintherapyandtheendothelialfunctionparametersinpatientswithtype2diabetesmellitus |
| _version_ |
1718429506123857920 |